WADA Adds Non-Diagnostic Carbon Monoxide Use to Prohibited Methods in 2026 Anti-Doping List
Starting in 2026, athletes will be banned from repeatedly inhaling carbon monoxide to artificially boost red blood cell production. The World Anti-Doping Agency has closed the controversial physiological loophole while preserving the method's use for single-dose diagnostic testing.
- Anti-Doping Regulators
- Prioritize athlete safety and clean competition by banning dangerous physiological loopholes.
- Sports Scientists
- Value carbon monoxide rebreathing as a crucial diagnostic tool for measuring hemoglobin mass.
- Endurance Athletes & Teams
- Seek every legal marginal gain to improve aerobic capacity and VO2 max.
The short version: starting January 1, 2026, athletes cannot use carbon monoxide to artificially boost their endurance. The World Anti-Doping Agency (WADA) has officially added the non-diagnostic use of carbon monoxide to its Prohibited List. For athletes across all disciplines—from Tour de France cyclists to mixed martial artists looking to build their gas tank—repeatedly inhaling the toxic gas to mimic altitude training is now a banned blood manipulation tactic.[1][3]
The ruling addresses a controversial physiological loophole that gained mainstream attention during the 2024 professional cycling season. Several elite teams were found using carbon monoxide rebreathers. While the teams insisted the devices were strictly for measuring blood values, the revelation sparked immediate concern among sports scientists. The fear was that the method could be weaponized to force the body into producing more red blood cells without the athlete ever leaving sea level.[2][7]
To understand why this matters for your own training, it helps to look at the underlying physiology. Carbon monoxide binds to hemoglobin—the protein in your red blood cells that carries oxygen—with an affinity roughly 200 times stronger than oxygen itself. When inhaled in controlled, repeated doses, it crowds out oxygen and induces a state of artificial hypoxia.[5][6]
Your body, sensing that it is starved of oxygen, responds exactly as it would at high altitude: it releases erythropoietin (EPO). This hormone stimulates the production of new red blood cells. For a combat sports athlete facing a grueling five-round fight, a higher red blood cell count translates directly to a higher VO2 max, better oxygen delivery to working muscles, and significantly delayed fatigue.[4][6]
Your body, sensing that it is starved of oxygen, responds exactly as it would at high altitude: it releases erythropoietin (EPO).
However, the line between a performance-enhancing dose and a highly toxic one is notoriously thin. Carbon monoxide is a poisonous gas; miscalculating the dose can lead to severe confusion, rapid heart rate, organ damage, or death. Recognizing these severe health risks, the Union Cycliste Internationale (UCI) lobbied WADA to implement a comprehensive ban before the practice could spread to other endurance and combat sports.[3][5]
Under the new M1.4 classification in the 2026 WADA code, the non-diagnostic use of carbon monoxide is strictly prohibited. WADA's medical committee concluded that while the gas can indeed increase erythropoiesis under certain conditions, the potential for fatal miscalculation far outweighs any theoretical athletic benefit. The message is clear: the risks of artificial hypoxia are not worth the physiological adaptations.[1][4]
Crucially, WADA has carved out a specific, practical exemption for diagnostic use. Sports scientists and team physicians can still employ single-dose carbon monoxide rebreathing tests to accurately measure an athlete's total hemoglobin mass. This allows coaches to safely track whether a legitimate high-altitude training camp is actually working, without crossing the line into active doping.[1][2]
The diagnostic test involves inhaling a small, precise volume of carbon monoxide, temporarily raising the blood's CO concentration to roughly six percent—comparable to the levels found in a heavy smoker. Because the gas clears the system within 24 hours, a single diagnostic application poses minimal long-term risk. By drawing a hard line between measurement and manipulation, WADA is protecting athlete safety while preserving a valuable tool for legitimate sports science.[2][7]
Viewpoints in depth
Diagnostic CO Rebreathing (The Permitted Measurement)
Using a single, controlled dose of carbon monoxide strictly to measure total hemoglobin mass.
The case for: It provides the most accurate available measurement of an athlete's red blood cell volume, allowing coaches to verify if a legitimate altitude camp is actually working. The case against: The equipment is expensive, requires specialized medical supervision, and temporarily reduces oxygen transport by raising blood CO levels to around 6 percent. The evidence: Over 20 years of sports science research validates the 'Schmidt method' as the gold standard for tracking hemoglobin changes. Fits well when: An elite athlete needs precise physiological profiling before and after a high-altitude training block. Does not fit when: Used outside a controlled clinical environment or applied to amateur athletes who do not require elite-level blood tracking.
Hypoxic CO Inhalation (The Banned Intervention)
Inhaling carbon monoxide in multiple sessions to artificially stimulate red blood cell production.
The case for: It effectively mimics the hypoxic stress of high altitude at sea level, triggering an endogenous EPO surge that increases aerobic capacity and VO2 max. The case against: It is now officially classified as doping under WADA's M1.4 rule, and miscalculating the dose of this highly toxic gas can lead to severe hypoxia, organ damage, or death. The evidence: Clinical studies confirm that chronic carbon monoxide exposure stimulates erythropoiesis, but the safety margins are dangerously narrow. Fits well when: Historically utilized in highly controlled, experimental research settings to study erythropoiesis and altitude adaptation mechanisms. Does not fit when: Applied to competitive athletes, as it violates the 2026 WADA Code and introduces severe risks of accidental carbon monoxide poisoning.
Key points
- WADA's 2026 Prohibited List bans the non-diagnostic use of carbon monoxide.
- Repeated inhalation of the gas artificially stimulates red blood cell production.
- The ban addresses a controversial practice popularized in professional cycling.
- Single-dose diagnostic testing to measure hemoglobin mass remains permitted.
- The ruling protects athletes from the severe health risks of carbon monoxide toxicity.
Sources
[1]World Anti-Doping AgencyAnti-Doping RegulatorsWADA publishes 2026 Prohibited List
Read on World Anti-Doping Agency →
[2]The GuardianEndurance Athletes & TeamsCarbon monoxide rebreathing, which may give riders an edge over rivals, caused controversy at this year's Tour de France
Read on The Guardian →
[3]The IndependentAnti-Doping RegulatorsWADA set to ban carbon monoxide rebreathing after doping concerns
Read on The Independent →
[4]road.ccEndurance Athletes & TeamsWADA to ban carbon monoxide rebreathers as a performance aid from 2026
Read on road.cc →
[5]TriathleteSports ScientistsCarbon monoxide rebreathing is under the microscope
Read on Triathlete →
[6]TrainingPeaksSports ScientistsWhat is Carbon Monoxide Rebreathing?
Read on TrainingPeaks →
[7]BikeRadarSports ScientistsCarbon monoxide rebreathing hit the headlines at the 2024 Tour de France
Read on BikeRadar →
Comments
Every angle. Every day.
Get fitness stories with full source coverage and perspective breakdowns delivered to your inbox.
